Literature DB >> 20232198

Bacteriophages and cancer.

Paulina Budynek1, Krystyna Dabrowska, Grzegorz Skaradziński, Andrzej Górski.   

Abstract

Bacteriophages can be used effectively to cure bacterial infections. They are known to be active against bacteria but inactive against eukaryotic cells. Nevertheless, novel observations suggest that phages are not neutral for higher organisms. They can affect physiological and immunological processes which may be crucial to their expected positive effects in therapies. Bacteriophages are a very differentiated group of viruses and at least some of them can influence cancer processes. Phages may also affect the immunological system. In general, they activate the immunological response, for example cytokine secretion. They can also switch the tumor microenvironment to one advantageous for anticancer treatment. On the other hand, bacteriophages are used as a platform for foreign peptides that may induce anticancer effects. As bacterial debris can interfere with bacteriophage activity, phage purification is significant for the final effect of a phage preparation. In this review, results of the influence of bacteriophages on cancer processes are presented which have implications for the perspective application of phage therapy in patients with cancer and the general understanding of the role of bacteriophages in the human organism.

Entities:  

Mesh:

Year:  2010        PMID: 20232198     DOI: 10.1007/s00203-010-0559-7

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  19 in total

1.  Grand challenge commentary: Synthetic immunology to engineer human immunity.

Authors:  David A Spiegel
Journal:  Nat Chem Biol       Date:  2010-12       Impact factor: 15.040

Review 2.  Virome and bacteriome: two sides of the same coin.

Authors:  Jonathan Stern; George Miller; Xin Li; Deepak Saxena
Journal:  Curr Opin Virol       Date:  2019-06-06       Impact factor: 7.090

Review 3.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

4.  Combination of Plant Virus Nanoparticle-Based in Situ Vaccination with Chemotherapy Potentiates Antitumor Response.

Authors:  Karin L Lee; Abner A Murray; Duc H T Le; Mee Rie Sheen; Sourabh Shukla; Ulrich Commandeur; Steven Fiering; Nicole F Steinmetz
Journal:  Nano Lett       Date:  2017-06-26       Impact factor: 11.189

5.  Phage treatment of human infections.

Authors:  Stephen T Abedon; Sarah J Kuhl; Bob G Blasdel; Elizabeth Martin Kutter
Journal:  Bacteriophage       Date:  2011-03

6.  Extracellular Vesicle Molecular Profiling for Diagnostic Purposes: An Application of Phage Display Technology.

Authors:  Stella Garcia Colombarolli; Alberto Vitali; Francesca Sciandra
Journal:  Methods Mol Biol       Date:  2023

Review 7.  Targeting the gut and tumor microbiota in cancer.

Authors:  Elizabeth M Park; Manoj Chelvanambi; Neal Bhutiani; Guido Kroemer; Laurence Zitvogel; Jennifer A Wargo
Journal:  Nat Med       Date:  2022-04-19       Impact factor: 87.241

8.  Enhancing and initiating phage-based therapies.

Authors:  Philip Serwer; Elena T Wright; Juan T Chang; Xiangan Liu
Journal:  Bacteriophage       Date:  2014-12-15

9.  Phenotypic evolution of therapeutic Salmonella enterica serovar Typhimurium after invasion of TRAMP mouse prostate tumor.

Authors:  Elizabeth Choe; Robert A Kazmierczak; Abraham Eisenstark
Journal:  MBio       Date:  2014-07-01       Impact factor: 7.867

10.  Selection of Novel Peptides Homing the 4T1 CELL Line: Exploring Alternative Targets for Triple Negative Breast Cancer.

Authors:  Vera L Silva; Debora Ferreira; Franklin L Nobrega; Ivone M Martins; Leon D Kluskens; Ligia R Rodrigues
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.